The Need for Speed... in Phenotypic Antimicrobial Susceptibility Testing
Tracking # 20-1268515
Price not reported
There are no ratings for this course
Learn moreCourse overview
Sepsis remains a top healthcare priority. 48.9 million cases of sepsis occur each year and the average cost per hospital stay for sepsis is double the average cost per stay across all other conditions. Timely and effective antibiotic treatment for sepsis patients is critical. For patients with serious infections (i.e. blood stream infections), reducing time to effective therapy has been associated with decreased mortality. There is a delicate balance between timely, broad-spectrum antibiotics and preventing the acceleration of antimicrobial resistance highlighting the need for more rapid phenotypic susceptibility testing. In this webinar, Dr. Linoj Samuel will highlight currently available technology enabling fast phenotypic antimicrobial susceptibility testing ("Fast AST"), potential applications, limitations, and considerations towards implementing novel technology to deliver improved patient outcomes.
Subject areas
This course counts toward the state boards and subject areas below.
American Board of Clinical Chemistry
Clinical Chemistry Diplomate
Molecular Diagnostics Diplomate
Toxicological Chemistry Diplomate
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
- Linoj Samuel, PhD, D(ABMM)
- Honorarium/Expenses: Biomerieux
- Board/Committee Membership/Advisory Board: Cepheid, NextGenDx
- Grant Research/Support: Biomerieux